New — Free Peptide Starter Guide (2026): 13 chapters, 34 cited studies

Get it free
ToolsCompareChonluten vs Noopept

Chonluten vs Noopept

Side-by-side comparison of key properties, dosing, and research.

Anti-Aging & Longevity
Chonluten
Cognitive Enhancement
Noopept
Summary
Chonluten is a tripeptide bioregulator (Glu-Asp-Leu) developed by Professor Vladimir Khavinson, tissue-specific to the bronchi and lungs. While related to Bronchogen (a tetrapeptide), Chonluten is a shorter tripeptide sequence. It supports bronchial mucosal cell function, promotes respiratory epithelial regeneration, and is used in protocols for COPD, chronic bronchitis, and pulmonary anti-aging.
Noopept is a potent dipeptide-derived nootropic from Russia, structurally related to piracetam but estimated to be 1,000 times more potent by mass. It enhances memory consolidation, learning, and recall while providing neuroprotection via BDNF and NGF upregulation.
Half-Life
Short (minutes for the peptide); sustained gene-regulatory effects
~5–10 minutes but metabolite (CPG) effects last hours
Admin Route
SubQ, Oral
Oral, Sublingual, Intranasal
Research
Typical Dose
10 mg per day
10–30 mg
Frequency
Daily for 10–30 days
1–2x daily
Key Benefits
  • Supports bronchial mucosal regeneration and repair
  • May improve mucociliary clearance in chronic respiratory conditions
  • Anti-inflammatory effects on bronchial epithelium
  • Pulmonary anti-aging and tissue preservation
  • Supports lung function in COPD and chronic bronchitis
  • Well tolerated in combination with other Khavinson bioregulators
  • Short tripeptide with efficient cellular penetration
  • Enhances memory formation and recall
  • Improves learning speed and cognitive processing
  • Neuroprotective via BDNF/NGF upregulation
  • Anxiolytic at low-to-moderate doses
  • Improves verbal fluency and information processing
  • Antioxidant (reduces oxidative damage in neurons)
  • May improve cognitive symptoms of mild cognitive impairment
Side Effects
  • Generally well tolerated
  • Mild injection site reactions possible
  • No significant adverse pulmonary events reported
  • Headaches (choline depletion — pair with choline source)
  • Irritability or anxiety at high doses
  • Overstimulation
  • Rare: brain fog with chronic use
  • +1 more
Stacks With